Company profile INZY

Inozyme Pharma Inc
we are a biopharmaceutical company specializing in the development of novel therapeutics to treat rare metabolic diseases. our area of expertise is in disorders of paradoxical mineralization and our lead drug is an enzyme replacement therapy in pre-clinical development.
Quarter analysis & expected interestLast update: February 08 2024 01:09:32.

After 38 days of this quarter the interest is at 25.0. Based on that we can calculate that during remaining 53 days it will total up to 60.0.
Inozyme Pharma expected interest is significantly lower compared to previous quarter (-76.8%) and same quarter last year (-70.7%).

YearQ1Q2Q3Q4
20190
129
inf% QoQ
117
-9.3% QoQ
40
-65.8% QoQ
2020 224
inf% YoY 460.0% QoQ
145
12.4% YoY -35.3% QoQ
117
0.0% YoY -19.3% QoQ
72
80.0% YoY -38.5% QoQ
2021 66
-70.5% YoY -8.3% QoQ
106
-26.9% YoY 60.6% QoQ
273
133.3% YoY 157.5% QoQ
151
109.7% YoY -44.7% QoQ
2022 285
331.8% YoY 88.7% QoQ
124
17.0% YoY -56.5% QoQ
227
-16.8% YoY 83.1% QoQ
89
-41.1% YoY -60.8% QoQ
2023 205
-28.1% YoY 130.3% QoQ
116
-6.5% YoY -43.4% QoQ
342
50.7% YoY 194.8% QoQ
259
191.0% YoY -24.3% QoQ
2024 25
-87.8% YoY -90.3% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Inozyme Pharma search interestLast update: February 08 2024 01:09:32.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 01:09:33.

The average 5 years interest of Inozyme Pharma was 11.92 per week.
The last year interest of Inozyme Pharma compared to the last 5 years has changed by 48.24%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 221.27%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 01:09:38.

After 38 days of this quarter the interest is at 104.0. Based on that we can calculate that during remaining 53 days it will total up to 249.0.
INZY stock expected interest is significantly higher compared to previous quarter (+41.5%) but similar to same quarter last year.

YearQ1Q2Q3Q4
201948
163
239.6% QoQ
39
-76.1% QoQ
93
138.5% QoQ
2020 50
4.2% YoY -46.2% QoQ
16
-90.2% YoY -68.0% QoQ
156
300.0% YoY 875.0% QoQ
114
22.6% YoY -26.9% QoQ
2021 95
90.0% YoY -16.7% QoQ
87
443.8% YoY -8.4% QoQ
78
-50.0% YoY -10.3% QoQ
166
45.6% YoY 112.8% QoQ
2022 74
-22.1% YoY -55.4% QoQ
110
26.4% YoY 48.6% QoQ
128
64.1% YoY 16.4% QoQ
81
-51.2% YoY -36.7% QoQ
2023 316
327.0% YoY 290.1% QoQ
425
286.4% YoY 34.5% QoQ
423
230.5% YoY -0.5% QoQ
176
117.3% YoY -58.4% QoQ
2024 104
-67.1% YoY -40.9% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and INZY stock search interestLast update: February 08 2024 01:09:38.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 01:09:39.

The average 5 years interest of INZY stock was 11.27 per week.
The last year interest of INZY stock compared to the last 5 years has changed by 132.21%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 258.98%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Inozyme Pharma login to provide analysis

Correlation between past revenue and Inozyme Pharma login search interest

There is not enough data for Inozyme Pharma login to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Inozyme Pharma login to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Inozyme Pharma news to provide analysis

Correlation between past revenue and Inozyme Pharma news search interest

There is not enough data for Inozyme Pharma news to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Inozyme Pharma news to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for INZ-701 clinical trials to provide analysis

Correlation between past revenue and INZ-701 clinical trials search interest

There is not enough data for INZ-701 clinical trials to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for INZ-701 clinical trials to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for ENPP1 deficiency treatment to provide analysis

Correlation between past revenue and ENPP1 deficiency treatment search interest

There is not enough data for ENPP1 deficiency treatment to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for ENPP1 deficiency treatment to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for ABCC6 deficiency treatment to provide analysis

Correlation between past revenue and ABCC6 deficiency treatment search interest

There is not enough data for ABCC6 deficiency treatment to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for ABCC6 deficiency treatment to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 01:09:42.

After 38 days of this quarter the interest is at 40.0. Based on that we can calculate that during remaining 53 days it will total up to 96.0.
calciphylaxis treatment expected interest is significantly lower compared to previous quarter (-66.9%) and same quarter last year (-43.2%).

YearQ1Q2Q3Q4
201964
173
170.3% QoQ
152
-12.1% QoQ
145
-4.6% QoQ
2020 195
204.7% YoY 34.5% QoQ
138
-20.2% YoY -29.2% QoQ
121
-20.4% YoY -12.3% QoQ
89
-38.6% YoY -26.4% QoQ
2021 358
83.6% YoY 302.2% QoQ
130
-5.8% YoY -63.7% QoQ
194
60.3% YoY 49.2% QoQ
163
83.1% YoY -16.0% QoQ
2022 210
-41.3% YoY 28.8% QoQ
187
43.8% YoY -11.0% QoQ
177
-8.8% YoY -5.3% QoQ
195
19.6% YoY 10.2% QoQ
2023 169
-19.5% YoY -13.3% QoQ
320
71.1% YoY 89.3% QoQ
278
57.1% YoY -13.1% QoQ
290
48.7% YoY 4.3% QoQ
2024 40
-76.3% YoY -86.2% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and calciphylaxis treatment search interestLast update: February 08 2024 01:09:42.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 01:09:43.

The average 5 years interest of calciphylaxis treatment was 14.51 per week.
The last year interest of calciphylaxis treatment compared to the last 5 years has changed by 28.67%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 57.29%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Inozyme Pharma headquarters to provide analysis

Correlation between past revenue and Inozyme Pharma headquarters search interest

There is not enough data for Inozyme Pharma headquarters to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Inozyme Pharma headquarters to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for INZY
Earnings date: 2024-03-20 After close
Company name: Inozyme Pharma Inc
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2025-08-27T17:42:28-04:00

SEC
SCHEDULE 13D/A Form - [Amend] General Statement of Acquisition of Beneficial Ownership - Inozyme Pharma, Inc. (0001693011) (Subject)

2025-07-01T08:45:00-04:00

PR Newswire
BioMarin Announces Completion of Acquisition of Inozyme

2025-06-20T19:31:24-04:00

SEC
DEFA14A Form - Additional definitive proxy soliciting materials and Rule 14(a)(12) material - Inozyme Pharma, Inc. (0001693011) (Filer)

2025-06-20T19:29:11-04:00

SEC
8-K Form - Current report, items 8.01 and 9.01 - Inozyme Pharma, Inc. (0001693011) (Filer)

2025-06-20T21:00:00Z

GlobeNewswire
Inozyme Pharma, Inc. Announces Postponement of 2025 Annual Meeting of Stockholders

2025-06-17T07:28:24-04:00

SEC
SC TO-T/A Form - [Amend] Tender offer statement by Third Party - Inozyme Pharma, Inc. (0001693011) (Subject)

2025-06-17T06:15:41-04:00

SEC
SC 14D9/A Form - [Amend] Solicitation, recommendation statements - Inozyme Pharma, Inc. (0001693011) (Subject)

2025-06-13T16:56:24-04:00

SEC
SC TO-T/A Form - [Amend] Tender offer statement by Third Party - Inozyme Pharma, Inc. (0001693011) (Subject)

2025-06-12T14:30:00-04:00

PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates INZY, SVT, HLGN on Behalf of Shareholders

2025-06-12T14:00:00-04:00

PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates INZY, SVT, HLGN on Behalf of Shareholders

2025-06-04T17:09:30-04:00

SEC
SCHEDULE 13G Form - Statement of Beneficial Ownership by Certain Investors - Inozyme Pharma, Inc. (0001693011) (Subject)

2025-06-04T16:51:51-04:00

SEC
SC 14D9/A Form - [Amend] Solicitation, recommendation statements - Inozyme Pharma, Inc. (0001693011) (Subject)

2025-06-04T16:32:35-04:00

SEC
SC TO-T/A Form - [Amend] Tender offer statement by Third Party - Inozyme Pharma, Inc. (0001693011) (Subject)

2025-06-02T07:35:39-04:00

SEC
8-K Form - Current report, item 5.02 - Inozyme Pharma, Inc. (0001693011) (Filer)

2025-06-02T07:14:55-04:00

SEC
SC 14D9 Form - Solicitation, recommendation statements - Inozyme Pharma, Inc. (0001693011) (Subject)